Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes

Y. Martinet, K. Yamauchi, Ronald Crystal

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Tumor necrosis factor (TNF), also called cachectin, is a mononuclear phagocyte-derived mediator with a broad range of biologic activities contributing to antineoplastic and antiviral defenses as well as mediating a variety of processes associated with acute and chronic inflammatory states, including endotoxin-induced shock. To evaluate the relative capacity of human tissue macrophages to produce this mediator, alveolar macrophages and blood monocytes from the same normal individuals were activated with lipopolysaccharide (LPS) and evaluated for TNF release and TNF mRNA transcript levels. Resting alveolar macrophages did not express TNF mRNA transcripts or release TNF. However, when activated, alveolar macrophages expressed TNF transcripts and synthesized and released TNF as evidenced by the presence of a 28 kDA mediator in LPS-activator alveolar macrophage supernatants that had cytotoxic activity for L-929 cells that was abrogated by anti-TNF antibodies and that coeluted with a pure TNF standard on a molecular sieve column. Interestingly, activated alveolar macrophages released severalfold more TNF than did autologous blood monocytes stimulated in a similar fashion and, in parallel, the alveolar macrophages expressed more TNF mRNA transcripts than activated blood monocytes. Thus, the ability to express the TNF gene and to release TNF apparently increases during maturation of blood monocytes into alveolar macrophages, suggesting that the release of TNF in the local milieu by activated tissue macrophages may be much more significant than the release of this mediator by circulating blood monocytes.

Original languageEnglish
Pages (from-to)659-665
Number of pages7
JournalAmerican Review of Respiratory Disease
Volume138
Issue number3
DOIs
Publication statusPublished - 1 Jan 1988
Externally publishedYes

Fingerprint

Phagocytes
Tumor Necrosis Factor-alpha
Lung
Alveolar Macrophages
Genes
Monocytes
Messenger RNA
Lipopolysaccharides
Macrophages
Endotoxins
Antineoplastic Agents
Antiviral Agents
Shock

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes. / Martinet, Y.; Yamauchi, K.; Crystal, Ronald.

In: American Review of Respiratory Disease, Vol. 138, No. 3, 01.01.1988, p. 659-665.

Research output: Contribution to journalArticle

@article{e0fa0676867743aa80bbf3d6183d5055,
title = "Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes",
abstract = "Tumor necrosis factor (TNF), also called cachectin, is a mononuclear phagocyte-derived mediator with a broad range of biologic activities contributing to antineoplastic and antiviral defenses as well as mediating a variety of processes associated with acute and chronic inflammatory states, including endotoxin-induced shock. To evaluate the relative capacity of human tissue macrophages to produce this mediator, alveolar macrophages and blood monocytes from the same normal individuals were activated with lipopolysaccharide (LPS) and evaluated for TNF release and TNF mRNA transcript levels. Resting alveolar macrophages did not express TNF mRNA transcripts or release TNF. However, when activated, alveolar macrophages expressed TNF transcripts and synthesized and released TNF as evidenced by the presence of a 28 kDA mediator in LPS-activator alveolar macrophage supernatants that had cytotoxic activity for L-929 cells that was abrogated by anti-TNF antibodies and that coeluted with a pure TNF standard on a molecular sieve column. Interestingly, activated alveolar macrophages released severalfold more TNF than did autologous blood monocytes stimulated in a similar fashion and, in parallel, the alveolar macrophages expressed more TNF mRNA transcripts than activated blood monocytes. Thus, the ability to express the TNF gene and to release TNF apparently increases during maturation of blood monocytes into alveolar macrophages, suggesting that the release of TNF in the local milieu by activated tissue macrophages may be much more significant than the release of this mediator by circulating blood monocytes.",
author = "Y. Martinet and K. Yamauchi and Ronald Crystal",
year = "1988",
month = "1",
day = "1",
doi = "10.1164/ajrccm/138.3.659",
language = "English",
volume = "138",
pages = "659--665",
journal = "American Journal of Respiratory and Critical Care Medicine",
issn = "1073-449X",
publisher = "American Thoracic Society",
number = "3",

}

TY - JOUR

T1 - Differential expression of the tumor necrosis factor/cachectin gene by blood and lung mononuclear phagocytes

AU - Martinet, Y.

AU - Yamauchi, K.

AU - Crystal, Ronald

PY - 1988/1/1

Y1 - 1988/1/1

N2 - Tumor necrosis factor (TNF), also called cachectin, is a mononuclear phagocyte-derived mediator with a broad range of biologic activities contributing to antineoplastic and antiviral defenses as well as mediating a variety of processes associated with acute and chronic inflammatory states, including endotoxin-induced shock. To evaluate the relative capacity of human tissue macrophages to produce this mediator, alveolar macrophages and blood monocytes from the same normal individuals were activated with lipopolysaccharide (LPS) and evaluated for TNF release and TNF mRNA transcript levels. Resting alveolar macrophages did not express TNF mRNA transcripts or release TNF. However, when activated, alveolar macrophages expressed TNF transcripts and synthesized and released TNF as evidenced by the presence of a 28 kDA mediator in LPS-activator alveolar macrophage supernatants that had cytotoxic activity for L-929 cells that was abrogated by anti-TNF antibodies and that coeluted with a pure TNF standard on a molecular sieve column. Interestingly, activated alveolar macrophages released severalfold more TNF than did autologous blood monocytes stimulated in a similar fashion and, in parallel, the alveolar macrophages expressed more TNF mRNA transcripts than activated blood monocytes. Thus, the ability to express the TNF gene and to release TNF apparently increases during maturation of blood monocytes into alveolar macrophages, suggesting that the release of TNF in the local milieu by activated tissue macrophages may be much more significant than the release of this mediator by circulating blood monocytes.

AB - Tumor necrosis factor (TNF), also called cachectin, is a mononuclear phagocyte-derived mediator with a broad range of biologic activities contributing to antineoplastic and antiviral defenses as well as mediating a variety of processes associated with acute and chronic inflammatory states, including endotoxin-induced shock. To evaluate the relative capacity of human tissue macrophages to produce this mediator, alveolar macrophages and blood monocytes from the same normal individuals were activated with lipopolysaccharide (LPS) and evaluated for TNF release and TNF mRNA transcript levels. Resting alveolar macrophages did not express TNF mRNA transcripts or release TNF. However, when activated, alveolar macrophages expressed TNF transcripts and synthesized and released TNF as evidenced by the presence of a 28 kDA mediator in LPS-activator alveolar macrophage supernatants that had cytotoxic activity for L-929 cells that was abrogated by anti-TNF antibodies and that coeluted with a pure TNF standard on a molecular sieve column. Interestingly, activated alveolar macrophages released severalfold more TNF than did autologous blood monocytes stimulated in a similar fashion and, in parallel, the alveolar macrophages expressed more TNF mRNA transcripts than activated blood monocytes. Thus, the ability to express the TNF gene and to release TNF apparently increases during maturation of blood monocytes into alveolar macrophages, suggesting that the release of TNF in the local milieu by activated tissue macrophages may be much more significant than the release of this mediator by circulating blood monocytes.

UR - http://www.scopus.com/inward/record.url?scp=0023762864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023762864&partnerID=8YFLogxK

U2 - 10.1164/ajrccm/138.3.659

DO - 10.1164/ajrccm/138.3.659

M3 - Article

VL - 138

SP - 659

EP - 665

JO - American Journal of Respiratory and Critical Care Medicine

JF - American Journal of Respiratory and Critical Care Medicine

SN - 1073-449X

IS - 3

ER -